Many Alzheimer’s patients are being cared for by family members that do not have any caregiver training; Results show that a program with targeted support services directed to these informal family caregivers could drive down costs while improving Alzheimer’s caregiver and patient experiences

 

In a bipartisan letter to Acting Administrator Slavitt, Klobuchar and 12 other senators urged the Centers for Medicare and Medicaid Services (CMS) to work to implement a program that fully evaluates how providing Alzheimer’s disease support services to caregivers would impact Medicare beneficiaries diagnosed with Alzheimer’s

 

WASHINGTON, D.C. – U.S. Senator Amy Klobuchar has urged the Centers for Medicare and Medicaid Services (CMS) to implement a program to support family caregivers of those with Alzheimer’s. Many Alzheimer’s patients are being cared for by family members that do not have any caregiver training. Results show that a program with targeted support services directed to these informal family caregivers could drive down costs while improving Alzheimer’s caregiver and patient experiences. In a bipartisan letter to CMS Acting Administrator Slavitt, Klobuchar and 12 other senators urged the Centers for Medicare and Medicaid Services to work to implement a program that fully evaluates how providing Alzheimer’s disease support services to caregivers would impact Medicare beneficiaries diagnosed with Alzheimer’s.

 

“Today, more than 15 million Americans are serving as a family caregiver to a loved one living with Alzheimer’s or dementia, providing nearly 18 billion hours of unpaid care annually. These loving but largely untrained and unsupported family caregivers face many challenges,” wrote the lawmakers. “Mounting evidence suggests that targeted support services directed to these informal family caregivers may help the caregiver prevent or mitigate these challenges and help keep an Alzheimer’s patient in the home setting for longer periods of time. We ask CMS to work to implement a demonstration program to more fully evaluate the impacts providing Alzheimer’s disease support services to caregivers would have on Medicare beneficiaries diagnosed with Alzheimer’s and related dementias, particularly on delaying or reducing their use of institutional long-term care and other health care services.”

 

Klobuchar is a leader on combating Alzheimer’s disease. She has consistently pushed her colleagues to support additional funding for Alzheimer’s research to help increase treatments and find a cure. In January, Klobuchar and Senator Susan Collins (R-ME) led a letter calling on President Obama to increase our nation’s funding for Alzheimer’s research as part of his fiscal year (FY) 2017 budget request. Last year, Klobuchar introduced a bipartisan Senate resolution declaring that the goal of preventing and effectively treating Alzheimer's by 2025 is an "urgent national priority."

 

The letter was also signed by Senators Shelley Moore Capito (R-WV), Debbie Stabenow (D-MI), Kelly Ayotte (R-NH), Sherrod Brown (D-OH), Bill Cassidy (R-LA), Susan Collins (R-ME), Kirsten Gillibrand (D-NY), Mark Kirk (R-IL), Chris Murphy (D-CT), Thom Tillis (R-NC), Jeanne Shaheen (D-NH) and Roger Wicker (R-MS).

 

The full text of the letter is below:

 

Dear Acting Director Slavitt:

 

Due to mounting cost and health burdens related to Alzheimer’s disease and related dementias on federal health programs, we are writing to urge the Centers for Medicare and Medicaid Services (CMS) to implement a program to support family caregivers of those with Alzheimer’s.  We were encouraged by Secretary Burwell’s remarks at the recent Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee Hearing on the FY17 Budget Request for the Health & Human Services Department on this topic.  We agree with the Secretary that we could do more and do better for this essential population.  In order to do so, we specifically ask that CMS implement a demonstration program to evaluate the cost-saving opportunities associated with providing targeted Alzheimer’s disease support services to caregivers.

 

Today, more than 15 million Americans are serving as a family caregiver to a loved one living with Alzheimer’s or dementia, providing nearly 18 billion hours of unpaid care annually.  These loving but largely untrained and unsupported family caregivers face many challenges, including high levels of caregiver stress and depression; declines in physical, mental and emotional health; and financial shortfalls driven by both the costs associated with such care as well as the lost wages that are commonplace for caregivers of this population.   Unfortunately, these immense challenges often lead to an Alzheimer’s patient’s premature entry into costly long-term care.  Yet, mounting evidence suggests that targeted support services directed to these informal family caregivers may help the caregiver prevent or mitigate these challenges and help keep an Alzheimer’s patient in the home setting for longer periods of time.  

 

One caregiver support model that has been shown to drive down costs while improving caregiver and patient experiences is the New York University Caregiver Intervention (NYUCI).  The NYUCI consists of individual and family counseling, participation in a caregiver support group, and ad-hoc counseling via telephone for caregivers and families to help them deal with the many challenges described above.   After more than 25 years in the field, this program has been shown to delay long-term care admission by more than a year and-a-half and to improve caregiver health and well-being.  Most recently, the program developers have validated the use of online training to rapidly and efficiently train counselors to provide the NYUCI. Results of a recent study involving more than 250 counselors demonstrated that their online training was as effective as in-person training, indicating further potential to rapidly and cost-effectively scale up such an intervention.

 

The NYUCI model has been replicated and produced similar results in other states and regions. One analysis of the potential cost savings impact of the NYUCI, published in Health Affairs in 2014, suggests that if rolled out broadly in the state of Minnesota the direct medical cost savings could be $996 million over a 15 year period, with a range of nearly $100 million to $2.64 billion depending on the rate of adoption of the intervention.  The Department of Veterans Affairs has implemented a similar type of intervention known as the Resources for Enhancing Alzheimer’s Caregiver Health or REACH program, which has also improved quality of life for caregivers.

 

Given this promising body of evidence, we ask CMS to work to implement a demonstration program to more fully evaluate the impacts providing Alzheimer’s disease support services to caregivers would have on Medicare beneficiaries diagnosed with Alzheimer’s and related dementias, particularly on delaying or reducing their use of institutional long-term care and other health care services.  We thank you in advance for giving this your full and prompt attention and would like to request a meeting with you and other members of your team over the coming weeks to discuss the path forward.

 

Sincerely,

 

###